Clinical Trials Directory

Trials / Completed

CompletedNCT03479346

Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors - A Study Protocol for a Double-blind, Randomised, Multi-center, Placebo-controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Gachon University Gil Oriental Medical Hospital · Academic / Other
Sex
Female
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The Purpose of this trial is to investigate the efficacy and safety of GGT on Korean obese Women with or without metabolic syndrome Risk factors

Conditions

Interventions

TypeNameDescription
DRUGGGTUsage: 3g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.
DRUGPlaceboUsage: 3g, three times a day, each taken before or between meals for 12 weeks Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

Timeline

Start date
2018-04-28
Primary completion
2020-10-01
Completion
2020-12-01
First posted
2018-03-27
Last updated
2021-04-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03479346. Inclusion in this directory is not an endorsement.

Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Facto (NCT03479346) · Clinical Trials Directory